What Drives Cardiovascular Disease?

November 10, 2026

Cardiovascular diseases are often the results of biological processes that have been developing for years. Deep inside the heart and blood vessels, inflammation, fibrosis, and tissue remodeling can already be active long before symptoms become evident been, influencing both disease progression and treatment response. This is why blood-based biomarkers are valuable, as they can identify active processes that may not be captured by conventional assessments alone.

Watch this video with our Director of Cardiovascular and Renal Research, Federica Genovese, to find out how our ECM biomarkers could enrich your next cardiovascular study.